The following projects are under development by BioLingus
Project 1 : Sublingual Liraglutide (Phase 1b/2a) (BL OPUS I)
Project 2 : Sublingual Semaglutide (BL OPUS II)
Project 3 : Sublingual Exenatide (BL OPUS III)
Project 4 : Sublingual insulin+ (fixed dose combination product of insulin and exenatide) (BL OPUS IV)
Other projects are in development.
One specific area of interest is to develop a sublingual dual incretin inhibitor (GLP1/GIP)
For more information on these products, please click OPUS Projects.
Project 5 : Sublingual IL2 (BL SLIT I)
Project 6 : Sublingual Interferon-alfa (BL SLIT II)
For more information, please click SLIT Projects.